Abstract
We reviewed the records of 33 patients with leukemia who experienced influenza during the period from October 2000 to March 2004. Three (38%) of the 8 patients who did not receive neuraminidase inhibitor therapy and none of the 25 patients who received it died of influenza pneumonia (P=.001). The use of neuraminidase inhibitor therapy seems to improve the outcome of influenza in patients with leukemia.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Adult
-
Aged
-
Antiviral Agents / therapeutic use*
-
Cohort Studies
-
Comorbidity
-
Female
-
Follow-Up Studies
-
Humans
-
Influenza, Human / diagnosis
-
Influenza, Human / drug therapy*
-
Influenza, Human / epidemiology*
-
Leukemia, Myeloid / diagnosis
-
Leukemia, Myeloid / epidemiology*
-
Male
-
Middle Aged
-
Neuraminidase / antagonists & inhibitors*
-
Neuraminidase / therapeutic use
-
Probability
-
Retrospective Studies
-
Risk Assessment
-
Survival Rate
-
Treatment Outcome
Substances
-
Antiviral Agents
-
Neuraminidase